Paxlovid significantly shortened the time to symptom relief (median, 13 vs 15 days; hazard ratio [HR], 1.27) and resolution ...

The number of COVID cases increased last week to 146. Cases had been falling in April and May and were as low as 31 at the ...

This year’s COVID-19 booster was rolled out in doctors offices and pharmacies in September, and attempts to address the rise ...

Stacker consulted research from Yale Medical School and the World Health Organization to find how SARS-CoV-2 has evolved ...

Children's risk of severe illness from COVID is less than that of adults, but they're not immune to the virus. "At the height ...

COVID-19 survivors may develop autoimmune conditions long-term, with risks varying by severity and vaccination status, ...

COVID-19 spreads from an infected person to others through respiratory droplets and aerosols that can vary in size, such as: large droplets that fall to the ground rapidly (within seconds or minutes) ...

Since 2020, COVID-19 has surged across the nation and the world. With variants like Omicron, Delta, Alpha and more, this ...

Verywell Health's content is for informational and educational purposes only. Our website is not intended to be a substitute ...

The shots got us through the pandemic. They helped us get back to normal. They provided immunity, especially when we hadn’t had natural infection frequently.” For most people, “the vaccines were the ...

Over the last few years, the SARS-CoV-2 virus, responsible for COVID-19, has undergone significant changes, evolving from the original wild-type strains to the highly transmissible Omicron variant.

Novavax has inked another settlement for a past COVID-19 vaccine supply deal. | Novavax has inked another settlement for a ...